Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 81

1.

Are we missing 'previously treated' smear-positive pulmonary tuberculosis under programme settings in India? A cross-sectional study.

Shewade HD, Gupta V, Satyanarayana S, Kharate A, Murali L, Deshpande M, Kumar N, Pandey P, Bajpai UN, Tripathy JP, Kathirvel S, Pandurangan S, Mohanty S, Ghule VH, Sagili KD, Prasad BM, Nath S, Singh P, Singh K, Jayaraman G, Rajeswaran P, Srivastava BK, Biswas M, Mallick G, Bera OP, Jaisingh AJJ, Naqvi AJ, Verma P, Ansari MS, Mishra PC, Sumesh G, Barik S, Mathew V, Lohar MRS, Gaurkhede CS, Parate G, Bale SY, Koli I, Bharadwaj AK, Venkatraman G, Sathiyanarayanan K, Lal J, Sharma AK, Kumar AM, Chadha SS.

Version 2. F1000Res. 2019 Mar 26 [revised 2019 Jan 1];8:338. doi: 10.12688/f1000research.18353.2. eCollection 2019.

PMID:
31297190
Free PMC Article
2.

Long Term Follow up of Cerebellar Ataxia CA) and MRI Lesions Which Responded to Copper (Cu) Supplementation (P12-055-19).

Rothkopf M, Venkatraman G.

Curr Dev Nutr. 2019 Jun 13;3(Suppl 1). pii: nzz035.P12-055-19. doi: 10.1093/cdn/nzz035.P12-055-19. eCollection 2019 Jun.

3.

Transcriptome analysis of Burkholderia pseudomallei SCV reveals an association with virulence, stress resistance and intracellular persistence.

Al-Maleki AR, Vellasamy KM, Mariappan V, Venkatraman G, Tay ST, Vadivelu J.

Genomics. 2019 Apr 10. pii: S0888-7543(18)30522-6. doi: 10.1016/j.ygeno.2019.04.002. [Epub ahead of print]

PMID:
30980902
4.

Patient characteristics, health seeking and delays among new sputum smear positive TB patients identified through active case finding when compared to passive case finding in India.

Shewade HD, Gupta V, Satyanarayana S, Pandey P, Bajpai UN, Tripathy JP, Kathirvel S, Pandurangan S, Mohanty S, Ghule VH, Sagili KD, Prasad BM, Nath S, Singh P, Singh K, Singh R, Jayaraman G, Rajeswaran P, Srivastava BK, Biswas M, Mallick G, Bera OP, Sahai KN, Murali L, Kamble S, Deshpande M, Kumar N, Kumar S, Jaisingh AJJ, Naqvi AJ, Verma P, Ansari MS, Mishra PC, Sumesh G, Barik S, Mathew V, Lohar MRS, Gaurkhede CS, Parate G, Bale SY, Koli I, Bharadwaj AK, Venkatraman G, Sathiyanarayanan K, Lal J, Sharma AK, Rao R, Kumar AMV, Chadha SS.

PLoS One. 2019 Mar 13;14(3):e0213345. doi: 10.1371/journal.pone.0213345. eCollection 2019.

5.

Variation in Care Delivery and Diagnostic Modalities Among the Medicare Population.

Venkatraman G.

JAMA Otolaryngol Head Neck Surg. 2019 Jan 31. doi: 10.1001/jamaoto.2018.3998. [Epub ahead of print] No abstract available.

PMID:
30703195
6.

Increased Expression of MicroRNA 551a by c-Fos Reduces Focal Adhesion Kinase Levels and Blocks Tumorigenesis.

Anuj, Arivazhagan L, Venkatraman G, Rayala SK.

Mol Cell Biol. 2019 Mar 19;39(7). pii: e00577-18. doi: 10.1128/MCB.00577-18. Print 2019 Apr 1.

PMID:
30670568
7.

Identification of Pak1 inhibitors using water thermodynamic analysis.

Biswal J, Jayaprakash P, Suresh Kumar R, Venkatraman G, Poopandi S, Rangasamy R, Jeyaraman J.

J Biomol Struct Dyn. 2019 Jan 20:1-19. doi: 10.1080/07391102.2019.1567393. [Epub ahead of print]

PMID:
30661460
8.

Active case finding among marginalised and vulnerable populations reduces catastrophic costs due to tuberculosis diagnosis.

Shewade HD, Gupta V, Satyanarayana S, Kharate A, Sahai KN, Murali L, Kamble S, Deshpande M, Kumar N, Kumar S, Pandey P, Bajpai UN, Tripathy JP, Kathirvel S, Pandurangan S, Mohanty S, Ghule VH, Sagili KD, Prasad BM, Nath S, Singh P, Singh K, Singh R, Jayaraman G, Rajeswaran P, Srivastava BK, Biswas M, Mallick G, Bera OP, Jaisingh AJJ, Naqvi AJ, Verma P, Ansari MS, Mishra PC, Sumesh G, Barik S, Mathew V, Lohar MRS, Gaurkhede CS, Parate G, Bale SY, Koli I, Bharadwaj AK, Venkatraman G, Sathiyanarayanan K, Lal J, Sharma AK, Rao R, Kumar AMV, Chadha SS; as members of the Axshya SAMVAD study group.

Glob Health Action. 2018;11(1):1494897. doi: 10.1080/16549716.2018.1494897.

9.

Mechanics of PAK1-A new molecular player in the arena of skin cancer.

Beesetti S, Surabhi RP, Rayala SK, Venkatraman G.

J Cell Physiol. 2018 Jan;234(1):969-975. doi: 10.1002/jcp.26925. Epub 2018 Aug 4.

PMID:
30076705
10.

Cloning and functional characterization of human Pak1 promoter by steroid hormones.

Raghavan S, Venkatraman G, Rayala SK.

Gene. 2018 Mar 10;646:120-128. doi: 10.1016/j.gene.2017.12.039. Epub 2017 Dec 21.

PMID:
29274909
11.

Current State of Overlapping, Concurrent, and Multiple-Room Surgery in Otolaryngology: A National Survey.

Cognetti DM, Nussenbaum B, Brenner MJ, Chi DH, McCormick ME, Venkatraman G, Zhan T, McKinlay AJ.

Otolaryngol Head Neck Surg. 2017 Dec;157(6):998-1004. doi: 10.1177/0194599817723897. Epub 2017 Aug 8.

PMID:
28787241
12.

DHQZ-17, a potent inhibitor of the transcription factor HNF4A, suppresses tumorigenicity of head and neck squamous cell carcinoma in vivo.

Tentu S, Nandarapu K, Muthuraj P, Venkitasamy K, Venkatraman G, Rayala SK.

J Cell Physiol. 2018 Mar;233(3):2613-2628. doi: 10.1002/jcp.26139. Epub 2017 Sep 7.

PMID:
28782802
13.

Helicobacter pylori outer inflammatory protein A (OipA) suppresses apoptosis of AGS gastric cells in vitro.

Al-Maleki AR, Loke MF, Lui SY, Ramli NSK, Khosravi Y, Ng CG, Venkatraman G, Goh KL, Ho B, Vadivelu J.

Cell Microbiol. 2017 Dec;19(12). doi: 10.1111/cmi.12771. Epub 2017 Aug 25.

PMID:
28776327
14.

Transcriptional regulation of ataxia-telangiectasia and Rad3-related protein by activated p21-activated kinase-1 protects keratinocytes in UV-B-induced premalignant skin lesions.

Beesetti S, Mavuluri J, Surabhi RP, Oberyszyn TM, Tober K, Pitani RS, Joseph LD, Venkatraman G, Rayala SK.

Oncogene. 2017 Nov 2;36(44):6154-6163. doi: 10.1038/onc.2017.218. Epub 2017 Jul 10.

PMID:
28692051
15.

KIBRA attains oncogenic activity by repressing RASSF1A.

Anuj, Arivazhagan L, Surabhi RP, Kanakarajan A, Sundaram S, Pitani RS, Mudduwa L, Kremerskothen J, Venkatraman G, Rayala SK.

Br J Cancer. 2017 Jun 29. doi: 10.1038/bjc.2017.192. [Epub ahead of print]

16.

UnPAKing RUNX3 functions-Both sides of the coin.

Kumar A, Sundaram S, Rayala SK, Venkatraman G.

Small GTPases. 2019 Jul;10(4):264-270. doi: 10.1080/21541248.2017.1322667. Epub 2017 Jun 23.

17.

Targeting IGF1R pathway in cancer with microRNAs: How close are we?

Kumar AS, Rayala SK, Venkatraman G.

RNA Biol. 2018 Mar 4;15(3):320-326. doi: 10.1080/15476286.2017.1338240. Epub 2018 Feb 1. Review.

18.

Efficacy of Dipeptide-Coated Magnetic Nanoparticles in Lung Cancer Models Under Pulsed Electromagnetic Field.

Baskar G, Ravi M, Panda JJ, Khatri A, Dev B, Santosham R, Sathiya S, Babu CS, Chauhan VS, Rayala SK, Venkatraman G.

Cancer Invest. 2017 Jul 3;35(6):431-442. doi: 10.1080/07357907.2017.1318894. Epub 2017 May 24.

PMID:
28537455
19.

Novel Glycopyrrolidine Compounds Inhibit Human Cancer Cell Proliferation and Induce Apoptotic Mode of Cell Death.

Bhoopalan H, Tentu S, R P, S P, Venu A, Raghunathan R, Pakala SB, Rayala SK, Venkatraman G.

Cancer Invest. 2017 Apr 21;35(4):215-224. doi: 10.1080/07357907.2016.1260139. Epub 2017 Mar 16.

PMID:
28301214
20.

Effective Strategies and Applications of Dendrimers in the Treatment of Ovarian Cancer.

Kesavan A, Pakala SB, Rayala SK, Venkatraman G.

Curr Pharm Des. 2017 Aug 30;23(21):3099-3104. doi: 10.2174/1381612823666170223165541. Review.

PMID:
28240171

Supplemental Content

Loading ...
Support Center